Seo, Y. David http://orcid.org/0000-0001-6837-5018
Ajami, Nadim http://orcid.org/0000-0002-3808-8576
Wargo, Jennifer A. http://orcid.org/0000-0003-3438-7576
Article History
First Online: 7 July 2023
Competing interests
: A.W. is an inventor of a US patent application (PCT/US17/53.717) submitted by the University of Texas MD Anderson Cancer Center, which covers methods to enhance immune checkpoint blockade responses by modulating the microbiome; reports compensation for the speaker’s bureau and honoraria from Imedex, Dava Oncology, Omniprex, Illumina, Gilead, PeerView, Physician Education Resource, MedImmune, Exelixis and Bristol Myers Squibb; and has served as a consultant or advisory board member for Roche/Genentech, Novartis, AstraZeneca, GlaxoSmithKline, Bristol Myers Squibb, Micronoma, OSE therapeutics, Merck and Everimmune. J.A.W. receives stock options from Micronoma and OSE therapeutics.